In May, the FDA announced an opportunity to submit feedback on what patients prefer in their medical devices to guide the agency’s...

The National Institutes of Health and the American Diabetes Association turned their attention to a key alternative to A1C in...

On Thursday, March 29, and on Friday, March 30, the Food and Drug Administration (FDA) will listen to public input...

FDA CDRH assembled an expert committee of patients and patient advocates who gathered for a public advisory committee meeting on October 11-12, 2017 in...

In preparation for The diaTribe Foundation's July 21st gathering, Glycemic Outcomes Beyond A1c: Standardization and Implementation, we've provided an exclusive look...

On Monday, August 29, 2016, The diaTribe Foundation participated in the FDA’s public workshop on Diabetes Outcome Measures Beyond Hemoglobin A1C...

On August 29, the FDA will host a public workshop on diabetes outcomes beyond A1C, a momentous event that the FDA...

diaTribe attended an FDA Advisory Committee meeting July 21 on whether Dexcom’s G5 CGM (continuous glucose monitor) should be approved for...